CHICAGO, October 28, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 ...

Based on the one-year price targets offered by 11 analysts, the average target price for Tempus AI Inc (NASDAQ:TEM) is $85.47 with a high estimate of $105.00 and a low estimate of $65.00. The average ...

A transaction report filed in January 2025 revealed the purchase of call options in the firm, which has since seen its stock price climb by over 185%. The Periodic Transaction Report, signed by Pelosi ...

The latest catalyst came after Tempus secured FDA clearance for its Tempus xR IVD device in late September, a breakthrough RNA sequencing tool designed to tailor therapies for cancer patients. The ...

Tempus AI has surged ~75% since August, but current valuations (~15x EV/forward revenue) are unsustainable for its hybrid business model. Tempus AI's Q2 2025 showed strong margin improvements, ...

Tempus AI shows strong revenue growth and diversification, but its premium valuation and lack of sustained profitability warrant a Hold rating. TEM's Data & Services segment is the key value driver, ...

Tempus Logix is an auto shipping broker that connects customers with the right auto shipping company for their needs. Its partner carriers ship new and used vehicles, classic cars, heavy machinery, ...

Tempus AI (NASDAQ: TEM) has been publicly traded for only 16 months, and it has been nothing short of a market standout over that time. Compared to its IPO price of $37, Tempus shares were up by a ...

One of the first actions by GSK's recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma's R&D productivity, starting ...

Current local time in Eastern Standard Time (Eastern Standard Time time zone). Get information about the Eastern Standard Time time zone. Local time and date, DST adjusted (where ever daylight saving ...